Fuji Pharma Co., Ltd. (TYO:4554)
Japan flag Japan · Delayed Price · Currency is JPY
1,845.00
+7.00 (0.38%)
Aug 25, 2026, 3:30 PM JST

Fuji Pharma Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Fuji Pharma stock has a consensus rating of "Buy" and an average price target of ¥3,000. The average 1-year stock price forecast is 62.60% higher than the current stock price, while the lowest is ¥2,300 (+24.66%) and the highest is ¥3,700 (+100.54%).

Price Target: ¥3,000 (+62.60%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥2,300¥3,000¥3,000¥3,700
Change+24.66%+62.60%+62.60%+100.54%

Analyst Ratings

The average analyst rating for Fuji Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingNov '25Feb '26May '26Jun '26Jul '26Aug '26
Strong Buy222111
Buy000000
Hold000111
Sell000000
Strong Sell000000
Total222222

Financial Forecast

Revenue This Year
60.34B
from 51.68B
Increased by 16.77%
Revenue Next Year
66.75B
from 60.34B
Increased by 10.61%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingSep 30, 2021Sep 30, 2022Sep 30, 2023Sep 30, 2024Sep 30, 2025Sep 30, 2026
Revenue
33.99B35.43B40.89B46.14B51.68B60.34B
Revenue Growth
0.58%4.23%15.42%12.84%12.01%16.77%
Gross Profit
14.75B14.56B16.52B17.84B20.76B25.01B
Gross Margin
43.40%41.10%40.39%38.68%40.18%41.45%
Operating Income
3.35B3.78B3.86B3.88B4.99B6.86B
Net Income
2.43B2.70B3.44B6.15B3.00B2.08B
Dividend / Share
29.0035.0037.0042.5045.5049.00
Dividend Growth
-20.69%5.71%14.87%7.06%7.69%
Free Cash Flow
1.39B-11.72B-4.26B599.13M535.50M-3.32B
No. Analysts
-----2
Financial currency is JPY.

Revenue Forecast

Revenue202620272028
High63.0B
Avg60.3B
Low57.7B

Revenue Growth

Revenue Growth202620272028
High
21.9%
Avg
16.8%
Low
11.6%

EPS Forecast

EPS202620272028
High-
Avg-
Low-

EPS Growth

EPS Growth20272028
High-
Avg-
Low-